Washington D.C., Aug 1, 2004 / 22:00 pm
A recent study by prominent medical organizations has determined that the latest contraceptive pills continue to pose a risk for embolism in women.
Thromboembolism consists of the formation of blood clots in the veins or arteries, which can travel to the brain or lungs and become life-threatening.
In an attempt to measure the relationship between thromboembolism and the use of today’s oral contraceptives that contain low dosages of estrogen, researchers of the Kaiser Permanente Medical Care Program in California and of Northwest University in Chicago conducted a study on women between the ages of 15 and 44.
The study examined 196 women with thromboembolism and compared them with 746 women who did not have the illness.